About Neuroprosthetics
The neural prosthetics systems rely on the detection and processing of brain activity involved in the planning and execution of movement intentions. Neuroprosthetics are used for individuals suffering an amputation as it restores the damaged motor, sensory, and autonomic functions by stimulating various parts of the nervous system such as nerves, muscles, spinal cord, and brain. Neurological scientists are developing neural interfaces to record and control signals directly from the nervous system. They are also developing a brain-spinal interface to restore voluntary gait control after a spinal cord injury (SCI).
Technavio’s analysts forecast the global neuroprosthetics market to grow at a CAGR of 7.08% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global neuroprosthetics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Neuroprosthetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott (St. Jude Medical)
• Boston Scientific
• Cochlear
• Medtronic
• Sonova
Other prominent vendors
• Atrotech
• Autonomic Technologies
• BrainGate
• Cyberonics
• DJO Global
• electroCore
• Mainstay Medical
• Nevro
• NeuroMetrix
• NeuroPace
• SensArs
• Soterix Medical
• Cogentix Medical
• Zynex Medical
Market driver
• Rising prevalence of SCIs
• For a full, detailed list, view our report
Market challenge
• High cost of neuroprosthetics products
• For a full, detailed list, view our report
Market trend
• Increasing focus on research
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• Market overview
• Neuromodulation devices
• Cognitive devices
PART 07: Market segmentation by end-users
• Market overview
• Hospitals
• ASCs
PART 08: Geographical segmentation
• Market scenario
• Neuroprosthetics market in Americas
• Neuroprosthetics market in EMEA
• Neuroprosthetics market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Increasing focus research
• Technological advancements
PART 12: Vendor landscape
• Vendor landscape
• Other prominent vendors
PART 13: Key vendor analysis
• Abbott (St. Jude Medical)
• Boston Scientific
• Cochlear
• Medtronic
• Sonova
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global neuroprosthetics market 2016-2021 ($ billions)
Exhibit 02: Five forces analysis
Exhibit 03: Global neuroprosthetics market by application 2016
Exhibit 04: Global neuroprosthetics market by neuromodulation devices 2016-2021 ($ billions)
Exhibit 05: Global neuroprosthetics market by cognitive devices 2016-2021 ($ billions)
Exhibit 06: Global neuroprosthetics market by geography 2016 (%)
Exhibit 07: Global neuroprosthetics market by geography 2021 (%)
Exhibit 08: Overview: Neuroprosthetics market in US
Exhibit 09: Neuroprosthetics market in Americas 2016-2021 ($ billions)
Exhibit 10: Overview: Neuroprosthetics market in Germany
Exhibit 11: Neuroprosthetics market in EMEA 2016-2021 ($ billions)
Exhibit 12: Overview: Neuroprosthetics market in Japan
Exhibit 13: Neuroprosthetics market in APAC 2016-2021 ($ billions)
Exhibit 14: Competitive structure analysis of global neuroprosthetics market 2016
Exhibit 15: Abbott: Key highlights
Exhibit 16: Abbott: Strength assessment
Exhibit 17: Abbott: Strategy assessment
Exhibit 18: Abbott: Opportunity assessment
Exhibit 19: Boston Scientific: Key highlights
Exhibit 20: Boston Scientific: Strength assessment
Exhibit 21: Boston Scientific: Strategy assessment
Exhibit 22: Boston Scientific: Opportunity assessment
Exhibit 23: Cochlear: Key highlights
Exhibit 24: Cochlear: Strength assessment
Exhibit 25: Cochlear: Strategy assessment
Exhibit 26: Cochlear: Opportunity assessment
Exhibit 27: Medtronic: Key highlights
Exhibit 28: Medtronic: Strength assessment
Exhibit 29: Medtronic: Strategy assessment
Exhibit 30: Medtronic: Opportunity assessment
Exhibit 31: Sonova: Key highlights
Exhibit 32: Sonova: Strength assessment
Exhibit 33: Sonova: Strategy assessment
Exhibit 34: Sonova: Opportunity assessment
